Carlyle Group’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.8M	Hold	3,496,808	–	–	0.37%	3
2025 Q4	$58M	Hold	3,496,808	–	–	0.43%	3
2025 Q3	$41.1M	Hold	3,496,808	–	–	0.95%	3
2025 Q2	$33.5M	Hold	3,496,808	–	–	0.67%	3
2025 Q1	$21.9M	Hold	3,496,808	–	–	0.58%	4
2024 Q4	$28.4M	Hold	3,496,808	–	–	0.68%	5
2024 Q3	$63.2M	Hold	3,496,808	–	–	6.62%	4
2024 Q2	$35.8M	Hold	3,496,808	–	–	3.4%	5
2024 Q1	$37.1M	Hold	3,496,808	–	–	2.34%	7
2023 Q4	$31.9M	Hold	3,496,808	–	–	1.54%	8
2023 Q3	$36.2M	Hold	3,496,808	–	–	1.57%	9
2023 Q2	$50.1M	Buy	3,496,808 +561,702	+19%	+$6.48M	1.78%	6
2023 Q1	$20.9M	Buy	+2,935,106	New	+$25.8M	0.62%	11